## CDW: CDW Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -2.0% below STRENGTH zone (3.0-6.0%); PEG 1.53 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($131.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Norris Perne & French LLP MI Lowers Stake in CDW Corporation $CDW**
- Source: MarketBeat | 20251229T123055 | Neutral | Relevance: 100%
- Norris Perne & French LLP MI significantly reduced its holdings in CDW Corporation by 91.8% in Q3, selling 48,843 shares and now owning 4,391 shares valued at $699,000. Despite this large institutional trim, analyst sentiment is a "Moderate Buy" with a consensus target of $186.43, even after recent shifts in price targets. Concurrently, insider Sona Chawla sold 7,400 shares, reducing her stake by over 20%, while CDW increased its quarterly dividend to $0.63 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $177 | $191 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 18 ($0.12M) |
| Sells | 4 ($1.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+2.2%)
- Blackrock Inc.: 9.2% (+8.2%)
- State Street Corpora: 4.5% (-0.4%)
- JPMORGAN CHASE & CO: 4.1% (+250.4%)
- Select Equity Group : 3.2% (+2.5%)

### Key Risks

1. Long-term trend broken: trading 15.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.53 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 43%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($1.2M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.1B |
| Beta | 1.06 |
| 52W Range | $135.63 - $222.92 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.53 |
| Forward P/E | 13.1 |
| Current P/E | 14.0 |
| YoY Growth | 6.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -5.3% to -2.0% (+3.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 5.0pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.2%) - potential reversal signal. Below SMA200 (0.85x), long-term trend not supportive. OFD pattern: +DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.98% (CS: 14) | Neutral |
| RSI_14 | 36.7 | Neutral |
| MACD Histogram | -0.48 | Bearish |
| vs SMA20 | 0.966x | Below |
| vs SMA50 | 0.947x | Below |
| vs SMA200 | 0.850x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $138.39
- **Stop Loss:** $131.55 (4.9% risk)
- **Target:** $145.23 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 160
- **Position Value:** $22,142.40
- **Portfolio %:** 22.14%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-11 (Est: $2.44)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.62 | $2.71 | +3.4% |
| 2025Q2 | $2.49 | $2.60 | +4.4% |
| 2025Q1 | $1.96 | $2.15 | +9.5% |
| 2024Q4 | $2.32 | $2.48 | +6.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*